0000950170-24-071401.txt : 20240610 0000950170-24-071401.hdr.sgml : 20240610 20240610170014 ACCESSION NUMBER: 0000950170-24-071401 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240606 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weis Holger CENTRAL INDEX KEY: 0001846984 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33038 FILM NUMBER: 241033587 MAIL ADDRESS: STREET 1: C/O ZIOPHARM ONCOLOGY, INC. STREET 2: ONE FIRST AVENUE, PARRIS BLDG 34 CITY: BOSTON STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc. CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2617 BISSONNET ST STREET 2: SUITE 225 CITY: HOUSTON STATE: TX ZIP: 77005 BUSINESS PHONE: (346) 355-4099 MAIL ADDRESS: STREET 1: 2617 BISSONNET ST STREET 2: SUITE 225 CITY: HOUSTON STATE: TX ZIP: 77005 FORMER COMPANY: FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC DATE OF NAME CHANGE: 20050919 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 4 1 ownership.xml 4 X0508 4 2024-06-06 0001107421 Alaunos Therapeutics, Inc. TCRT 0001846984 Weis Holger C/O ALAUNOS THERAPEUTICS, INC. 2617 BISSONNET ST, SUITE 225 HOUSTON TX 770005 true false false false false Employee Stock Option (right to buy) 1.03 2024-06-06 4 A false 19200 0.00 A 2034-06-05 Common Stock 19200 19200 D Employee Stock Option (right to buy) 1.03 2024-06-06 4 A false 4524 0.00 A 2034-06-05 Common Stock 4524 4524 D One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon. These options are fully vested as of June 6, 2024. /s/ Melinda Lackey, Attorney-in-Fact 2024-06-10